GLAVELSA

Class [005]
Veterinary preparations for the prevention and the treatment of metabolic diseases, namely renal diseases, liver diseases, pancreas diseases, digestive system disorders, gastrointestinal diseases and disorders, obesity; veterinary pharmaceutical preparations for the treatment of diabetes; veterinary pharmaceutical preparations for the prevention and the treatment of cardiovascular diseases; veterinary pharmaceutical preparations for the prevention and the treatment of neurological and neurodegenerative diseases and disorders, namely, epilepsy, central nervous system disorders, namely, ocular motility disorders, anxiety, brain injury, encephalitis; veterinary preparations for the prevention and the treatment of musculoskeletal diseases and disorders, namely, connective tissue diseases, cartilage injuries, osteoarthritis, rheumatoid arthritis, psoriatic arthritis, gout, spondylarthritis osteoporosis, osteopenia and associated fragility fractures, traumatic fractures; veterinary pharmaceutical preparations for the prevention and treatment of tendon and muscle damage and injuries; veterinary preparation preparations against bacterial and viral infections, namely, antibiotics, anti-infectives, antivirals; veterinary pharmaceutical preparations for the treatment of the respiratory system; veterinary preparations namely, antiparasitic; veterinary preparations for the treatment of inflammatory diseases namely, anti-inflammatory medications; veterinary pharmaceutical preparations for udder care; veterinary vaccines; sedatives for animals; pain relief medication for veterinary purposes; veterinary preparations, namely, stem cells for veterinary use; veterinary preparations, namely, surgical implants comprising living tissue and grown from stem cells for veterinary use.